Our mission is to transform cancer patients
into cancer survivors
We are moving forward confidently to realize our mission and create value
We are committed to providing hope in the face of despair by developing a tumor-targeting drug (SONALA-001) together with MR-guided focused ultrasound as sonodynamic therapy (SDT). This combination has the potential to be a safe and effective noninvasive treatment for cancer.
SonALAsense is the first company to advance SDT into clinical trials.
Soundly Defeating Cancer
Our mission is to create
Clinical trials now recruiting, Contact Us to learn more about eligibility.